Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
P311, also known as Neuronal regeneration related protein (NREP) or Neural protein 3.1, is an 8 kDa intracellular protein/peptide that plays a significant role in tissue repair and regeneration. It promotes angiogenesis, re-epithelialization, and M2 macrophage polarization, which are crucial for effective wound healing. Its functions are mediated through interactions with several signaling pathways, including the TGF-βRII-Smad, Akt, and mTOR pathways, and by upregulating factors like the IL-4 receptor and vascular endothelial growth factor (VEGF). P311 is being investigated as a therapeutic agent, particularly in formulations like microspheres and micelles, to enhance wound healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on P311.